Table 1.
Age (years), mean ± SD (range) | 50.6 ± 16 (26–70) |
Gender (male/female), n (%) | 7 (58.3)/5 (41.7) |
Hypertension, n (%) | 9 (91.6) |
Diabetes mellitus, n (%) | 8 (66.7) |
Dyslipidaemia, n (%) | 10 (83.3) |
Diagnosis CKD, n (%)a (two cases RB) | |
Obesity | 7 (58.3) |
Diabetic nephropathy | 4 (33.3)a |
Chronic glomerular disease | 1 (8.3)a |
Fatty liver, n (%) | 8 (66.7) |
Body weight (kg), mean ± SD (range) | 116 ± 23.2 (89.7–173.5) |
BMI (kg/m2), mean ± SD (range) | 41.1 ± 4.4 (35.1–48.1) |
Body fat (%), mean ± SD | 42.5 ± 7.5 |
Waist circumference (cm), mean ± SD (range) | 127 ± 11.4 (111–148) |
Hip circumference (cm), mean ± SD (range) | 128.3 ± 11.9 (105–145) |
eGFR (MDRD; mL/min), mean ± SD | 96.8 ± 49.8 |
Proteinuria (g/24 h), mean ± SD | 2.6 ± 2.9 |
Median (IQR) | 1.6 (1–2.7) |
Concomitant medication, n (%) | |
RAAS blocker | 12 (100) |
Insulin | 5 (41.7) |
Oral anti-diabetics | 5 (41.7) |
Statins | 7 (58.3) |
Fibrates | 3 (25) |
Patients with renal biopsy; one patient with diabetic nephropathy and the other with chronic glomerular disease.